Table of Contents Author Guidelines Submit a Manuscript
The Scientific World Journal
Volume 2015, Article ID 495271, 7 pages
http://dx.doi.org/10.1155/2015/495271
Research Article

Formulation and Evaluation of Galantamine Gel as Drug Reservoir in Transdermal Patch Delivery System

1Department of Chemistry, Faculty of Science, Universiti Putra Malaysia, 43300 Serdang, Selangor, Malaysia
2Laboratory of Molecular Biomedicine, Institute of Bioscience, Universiti Putra Malaysia, 43300 Serdang, Selangor, Malaysia

Received 8 October 2014; Revised 15 January 2015; Accepted 4 February 2015

Academic Editor: Herbert Budka

Copyright © 2015 Woo Fong Yen et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. P. K. Mukherjee, V. Kumar, M. Mal, and P. J. Houghton, “Acetylcholinesterase inhibitors from plants,” Phytomedicine, vol. 14, no. 4, pp. 289–300, 2007. View at Publisher · View at Google Scholar · View at Scopus
  2. E. A. Adewusi, N. Moodley, and V. Steenkamp, “Antioxidant and acetylcholinesterase inhibitory activity of selected southern African medicinal plants,” South African Journal of Botany, vol. 77, no. 3, pp. 638–644, 2011. View at Publisher · View at Google Scholar · View at Scopus
  3. G. Oboh, A. O. Ademiluyi, and A. J. Akinyemi, “Inhibition of acetylcholinesterase activities and some pro-oxidant induced lipid peroxidation in rat brain by two varieties of ginger (Zingiber officinale),” Experimental and Toxicologic Pathology, vol. 64, no. 4, pp. 315–319, 2012. View at Publisher · View at Google Scholar · View at Scopus
  4. S. Rattan and M. Kassem, Prevention and Treatment of Age-Related Diseases, Springer, 7th edition, 2006.
  5. A. L. Harvey, “The pharmacology of galanthamine and its analogues,” Pharmacology and Therapeutics, vol. 68, no. 1, pp. 113–128, 1995. View at Publisher · View at Google Scholar · View at Scopus
  6. K. Takata, Y. Kitamura, M. Saeki et al., “Galantamine-induced amyloid-β clearance mediated via stimulation of microglial nicotinic acetylcholine receptors,” The Journal of Biological Chemistry, vol. 285, no. 51, pp. 40180–40191, 2010. View at Publisher · View at Google Scholar · View at Scopus
  7. K. B. Patel, A. V. Patel, V. J. Patel, J. B. Dave, and C. N. Patel, “Quantitative determination of galantamine hydrobromide in pharmaceutical dosage form by RP- high performance liquid chromatography,” Journal of Chemical and Pharmaceutical Research, vol. 2, no. 2, pp. 36–43, 2010. View at Google Scholar
  8. G. Lefèvre, G. Sedek, H.-L. A. Huang et al., “Pharmacokinetics of a rivastigmine transdermal patch formulation in healthy volunteers: relative effects of body site application,” Journal of Clinical Pharmacology, vol. 47, no. 4, pp. 471–478, 2007. View at Publisher · View at Google Scholar · View at Scopus
  9. A. Alexander, S. Dwivedi, Ajazuddin, T. K. Giri, S. Saraf, and D. K. Tripathi, “Approaches for breaking the barriers of drug permeation through transdermal drug delivery,” Journal of Controlled Release, vol. 164, no. 1, pp. 26–40, 2012. View at Publisher · View at Google Scholar · View at Scopus
  10. E. Keleb, R. K. Sharma, E. B. Mosa, and A.-A. Z. Aljahwi, “Transdermal drug delivery system-design and evaluation,” International Journal of Advances in Pharmaceutical Sciences, vol. 1, no. 3, 2010. View at Google Scholar · View at Scopus
  11. S. Jana, S. Manna, A. K. Nayak, K. K. Sen, and S. K. Basu, “Carbopol gel containing chitosan-egg albumin nanoparticles for transdermal aceclofenac delivery,” Colloids and Surfaces B: Biointerfaces, vol. 114, pp. 36–44, 2014. View at Publisher · View at Google Scholar · View at Scopus
  12. G. P. Roberts and H. A. Barnes, “New measurements of the flow-curves for Carbopol dispersions without slip artefacts,” Rheologica Acta, vol. 40, no. 5, pp. 499–503, 2001. View at Publisher · View at Google Scholar · View at Scopus
  13. M. T. Islam, N. Rodríguez-Hornedo, S. Ciotti, and C. Ackermann, “Rheological characterization of topical carbomer gels neutralized to different pH,” Pharmaceutical Research, vol. 21, no. 7, pp. 1192–1199, 2004. View at Publisher · View at Google Scholar · View at Scopus
  14. B. W. Kemppainen and W. G. Reifenrath, Methods for Skin Absorption, CRC Press, New York, NY, USA, 1990.
  15. P. Batheja, L. Sheihet, J. Kohn, A. J. Singer, and B. Michniak-Kohn, “Topical drug delivery by a polymeric nanosphere gel: formulation optimization and in vitro and in vivo skin distribution studies,” Journal of Controlled Release, vol. 149, no. 2, pp. 159–167, 2011. View at Publisher · View at Google Scholar · View at Scopus
  16. C.-W. Park, D.-D. Son, J.-Y. Kim et al., “Investigation of formulation factors affecting in vitro and in vivo characteristics of a galantamine transdermal system,” International Journal of Pharmaceutics, vol. 436, no. 1-2, pp. 32–40, 2012. View at Publisher · View at Google Scholar · View at Scopus
  17. Y. Gao, J. Liang, J. Liu, and Y. Xiao, “Double-layer weekly sustained release transdermal patch containing gestodene and ethinylestradiol,” International Journal of Pharmaceutics, vol. 377, no. 1-2, pp. 128–134, 2009. View at Publisher · View at Google Scholar · View at Scopus
  18. W. J. Fasano, W. F. ten Berge, M. I. Banton, M. Heneweer, and N. P. Moore, “Dermal penetration of propylene glycols: measured absorption across human abdominal skin in vitro and comparison with a QSAR model,” Toxicology in Vitro, vol. 25, no. 8, pp. 1664–1670, 2011. View at Publisher · View at Google Scholar · View at Scopus
  19. P. Santos, A. C. Watkinson, J. Hadgraft, and M. E. Lane, “Influence of penetration enhancer on drug permeation from volatile formulations,” International Journal of Pharmaceutics, vol. 439, no. 1-2, pp. 260–268, 2012. View at Publisher · View at Google Scholar · View at Scopus
  20. L. Trottet, C. Merly, M. Mirza, J. Hadgraft, and A. F. Davis, “Effect of finite doses of propylene glycol on enhancement of in vitro percutaneous permeation of loperamide hydrochloride,” International Journal of Pharmaceutics, vol. 274, no. 1-2, pp. 213–219, 2004. View at Publisher · View at Google Scholar · View at Scopus